Epoch Biodesign Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Epoch Biodesign Ltd. - overview
Established
2019
Location
London, England, UK
Primary Industry
Environmental Services
About
Based in London, UK, and founded in 2019 by CEO Jacob Nathan, and Douglas Kell, E Epoch Biodesign Ltd. , a. k. a.
Epoch Biodesign is a biodesign company developing natural solutions to scale and industrialize life for a healthy planet. In April 2026, Epoch Biodesign Ltd. raised EUR 3. 7 million in venture funding from Mundi Ventures.
Epoch Biodesign is a biotechnology company focused on developing sustainable solutions for plastic and textile waste through advanced enzymatic recycling. The company uses artificial intelligence, synthetic biology, and materials science to design specialized enzymes that break down difficult-to-recycle materials such as mixed plastics and textiles into high-purity chemical building blocks, which can then be reused to create new, virgin-quality materials. Its platform operates at relatively low temperatures and aims to enable infinite recycling, reducing energy use and emissions compared to traditional recycling methods.
Current Investors
Amadeus Capital Partners, Plug and Play, BoxGroup
Primary Industry
Environmental Services
Sub Industries
Biotechnology, Pollution Control, Recycling, Application Integration Software
Website
www.epochbiodesign.com
Verticals
Artificial Intelligence, Clean Technology, Cloud Computing, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Epoch Biodesign Ltd. - financials
| Fiscal Year Ended | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|
| Revenue (USD) | - | - |
| % Revenue Growth (YoY) | - | - |
| EBITDA (USD) | - | - |
| Operating Income (USD) | - | - |
| Operating Margin | - | - |
| % EBITDA Margin | - | - |
| NET Income (USD) | - | - |
| % Net Margin | - | - |
Epoch Biodesign Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.